What is the next step in management for a 15‑year‑old female with iron‑deficiency anemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Next Step: Start Empiric Oral Iron Therapy Immediately

Begin oral iron supplementation at 60–120 mg elemental iron daily, taken between meals, and recheck hemoglobin in 4 weeks to confirm the diagnosis. 1

Rationale for Empiric Treatment

This 15-year-old female presents with classic laboratory findings of iron-deficiency anemia:

  • Microcytic anemia (MCV 66.2 fL, normal ~80–100) with marked hypochromasia (2+) and microcytosis (2+) 2
  • Elevated RBC count (6.03, above normal ~4.2–5.4 for females) combined with low MCV is highly suggestive of iron deficiency rather than thalassemia trait 1
  • Elevated RDW (16.6%, above normal ≤14%) strongly favors iron deficiency over thalassemia trait, which typically shows normal RDW 1, 2
  • Low serum iron (45 µg/dL, normal ~50–170) confirms inadequate iron availability 2

The CDC permits a presumptive diagnosis of iron-deficiency anemia in otherwise healthy adolescent girls who are not acutely ill, allowing immediate initiation of empiric therapy without waiting for additional confirmatory tests. 1

Treatment Protocol

Dosing and Administration

  • Prescribe 60–120 mg elemental iron daily (e.g., ferrous sulfate 325 mg contains 65 mg elemental iron; give 1–2 tablets daily) 1, 2
  • Administer between meals to maximize absorption 1, 2
  • Provide dietary counseling emphasizing heme iron sources (meat, poultry, fish with 15–35% bioavailability) and vitamin C co-ingestion to enhance non-heme iron absorption 1, 2

Confirmation of Diagnosis at 4 Weeks

  • Recheck hemoglobin after 4 weeks of therapy 1, 2
  • A rise of ≥1 g/dL hemoglobin (or ≥3% hematocrit) confirms iron-deficiency anemia and validates the empiric approach 1, 2
  • If confirmed, continue iron for an additional 2–3 months to replenish iron stores 1, 2

Final Monitoring

  • Reassess hemoglobin approximately 6 months after completing therapy 1
  • Consider annual screening if ongoing risk factors persist (heavy menstrual bleeding, restrictive diet, athletic activity) 1

When to Obtain Additional Testing

If hemoglobin fails to rise ≥1 g/dL after 4 weeks despite documented adherence, obtain: 1

  • Serum ferritin: <15 µg/L confirms iron deficiency; ≥15 µg/L suggests alternative etiology 1, 2
  • C-reactive protein (CRP): to detect inflammation that can falsely elevate ferritin and mask iron deficiency 1
  • Transferrin saturation: <20% indicates iron-restricted erythropoiesis 1
  • Hemoglobin electrophoresis: only if microcytosis persists with normal iron studies, especially in patients of African, Mediterranean, or Southeast Asian ancestry, to detect thalassemia trait 1

Key Risk Factors to Assess

Evaluate for common causes of iron deficiency in adolescent females: 1, 2

  • Heavy or prolonged menstrual bleeding (most common cause in this population)
  • Low dietary iron intake (vegetarian/vegan diets, restrictive eating)
  • High-impact or endurance sports participation
  • Prior history of iron-deficiency anemia

Critical Pitfalls to Avoid

  • Do not delay iron therapy while awaiting ferritin results; the 4-week hemoglobin response serves as diagnostic confirmation 1, 2
  • Do not order hemoglobin electrophoresis now; with RDW >14% and low iron, this pattern indicates iron deficiency, not thalassemia trait 2
  • Do not stop iron when hemoglobin normalizes; an additional 2–3 months is required to replenish stores 1, 2
  • Do not assume all microcytic anemia is iron deficiency; thalassemia trait can coexist, but the elevated RDW here points to iron deficiency 1
  • Do not rely solely on hemoglobin and hematocrit; these fall only after severe iron depletion 1

References

Guideline

Iron Supplementation Guidelines for Adolescent Females

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Iron Deficiency in Adolescent Females

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What oral iron formulation provides the highest absorption and what is the recommended dosing for an adult with iron‑deficiency anemia?
What is the dose of iron sucrose (iron sucrose) for a 171-pound child with iron deficiency anemia?
What is the differential diagnosis and treatment for a patient with dyspnea (shortness of breath) prior to menstruation, extreme fatigue, memory problems, motor problems, and muscle weakness?
What is the diagnosis and management for a 17-year-old female with mild iron deficiency anemia and abnormal complete blood count (CBC) results?
Can iron deficiency cause bruising?
What is the appropriate next step in management for a patient with heterogeneously dense (BI-RADS C) breasts who has a right central breast focal asymmetry at the 12‑o’clock anterior depth and a benign‑appearing mass with a biopsy marker in the left breast?
In a 75‑year‑old male with type 2 diabetes on metformin 1000 mg twice daily, admitted for chimeric antigen receptor T‑cell (CAR‑T) therapy, weight 80 kg, BMI 28, serum creatinine 1.54 mg/dL (eGFR ≈47 mL/min), who missed his metformin dose and now has fasting glucose ~135 mg/dL but post‑prandial glucose 259–288 mg/dL, should I start basal insulin glargine (Lantus) and use rapid‑acting insulin correction for hyperglycemia?
In an adult patient weighing at least 50 kg with normal liver function and not pregnant, is valproic acid 1000 mg three times daily an acceptable treatment for seizure disorder?
A patient develops shortness of breath after initiating an ACE inhibitor; what should be evaluated (e.g., cough, angioedema) and how should it be managed?
What is the clinical significance of amorphous crystals on urinalysis and how should they be assessed and managed?
How should I evaluate and manage an adult presenting with left‑leg tingling, weakness, and numbness consistent with sciatica, assuming no trauma, infection, malignancy, or prior spinal surgery?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.